Related Experiment Video
Updated: Jul 13, 2026
10:50
Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
Published on: May 1, 2019
Good manufacturing practice for immunological veterinary medicinal products
1Veterinary Medicines Directorate, Woodham Lane, New Haw, Addlestone, Surrey KT15 3LS, United Kingdom.
Summary
Good Manufacturing Practice (GMP) ensures the quality of immunological veterinary medicinal products (IVMPs). Adhering to GMP guidelines minimizes manufacturing risks, enhancing the safety and efficacy of IVMPs globally.
Area of Science:
- Veterinary Medicine
- Pharmaceutical Manufacturing
- Immunology
Background:
- Good Manufacturing Practice (GMP) is crucial for producing immunological veterinary medicinal products (IVMPs).
- Specific risks in IVMP manufacturing include contamination, cross-contamination, environmental and operator safety, process variability, and testing limitations.
- Existing EU GMP guidelines (Annex 5 and Annex 1) address these specific concerns for IVMPs.
Purpose of the Study:
- To highlight the importance of maintaining GMP in IVMP manufacture.
- To discuss the specific risks associated with IVMP production.
- To advocate for the extension and harmonization of GMP requirements for IVMPs worldwide.
Main Methods:
- Review of existing Good Manufacturing Practice (GMP) guidelines relevant to medicinal products.
- Analysis of specific risks inherent in the manufacture of immunological veterinary medicinal products (IVMPs).
- Examination of EU GMP guidelines (Annex 5 and Annex 1) for IVMP production.
Main Results:
- GMP is essential for ensuring the quality and safety of IVMPs.
- Unique manufacturing challenges necessitate specific GMP considerations.
- Harmonized global GMP standards can improve IVMP availability.
Conclusions:
- Maintaining rigorous GMP standards is vital for the safe and effective production of IVMPs.
- Addressing specific IVMP manufacturing risks through tailored GMP guidance is necessary.
- Global harmonization of GMP for IVMPs will increase access to high-quality products.
Related Concept Videos
01:26Good Manufacturing Practices
Good Manufacturing Practices (GMP) constitute a foundational set of guidelines that ensure the production of safe, consistent, and high-quality products, particularly in industries such as pharmaceuticals, biotechnology, and food processing. These protocols encompass all aspects of production, from the sourcing of raw materials to the final distribution of the finished product.A core pillar of GMP is stringent hygiene and sanitation across all production environments. This includes routine...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
01:18Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...